AfriNEXT project aims to develop and promote a vibrant, strong and sustainable research culture Africa. The project will create a critical mass of African world-class researchers capable of carrying out high quality research on local health priorities with a strong emphasis on maternal and child health. It is a great pleasure to collaborate with research and academic hubs of Burkina Faso, Ghana, Guinea, Cameroon, the Democratic Republic of Congo and Ethiopia, lead by Prof. Seni Kouanda.
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including
“This project will improve malaria prevention strategies for both children, pregnant women and families as a whole as the study is being conducted in families which will raise awareness of
Pregnant women, babies and children under 5 years of age are the most vulnerable to malaria. In 2018, around 11 million pregnant women and 24 million children got malaria. Furthermore,